The BYLUNZO brand, founded in 2014 (United Kingdom), from 1722 sister brands and 17477 competing brands. BYLUNZO is a brand of GSK PLC, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of GSK PLC is GB00BN7SWP63. BYLUNZO is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
GSK PLC
(BYLUNZO)
over 5 years*
EUR 16.10